The role of inhibins and activins in prostate cancer pathogenesis

Endocrine-Related Cancer

Volumn 7, Issue 4, 2000, Pages 243-256

  Dowling, C R ^a   Risbridger, G P ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; FOLLISTATIN; FOLLITROPIN; INHIBIN; LIGAND; PROTEIN SUBUNIT; TRANSFORMING GROWTH FACTOR BETA;

CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CARCINOGENESIS; HUMAN; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW;

ACTIVINS; ANIMALS; HUMANS; INHIBINS; MALE; PROSTATE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TESTIS;

EID: 0034473268     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0070243     Document Type: Review

References (89)

1. Identification of genetic markers for prostatic cancer progression
2. Follistatin and activin A production by the male reproductive tract
3. Fifteen-year survival with prostate cancer in Sweden
4. Bone morphogenic protein 6 in skeletal metastases from prostate cancer and other common human malignancies
5. TGFb in prostate cancer: A growth inhibitor that can enhance tumorigenicity
6. Evidence for the prostatic origin of immunoreactive inhibin-like material in human seminal plasma
7. Role of transforming growth factor beta in human disease
8. Inhibin: Definition and nomenclature, including related substances
9. Inhibin and ovarian cancer
10. Smad4 and FAST-1 in the assembly of activin-responsive factor
11. Activin inhibition of prostate cancer cell growth: Selective actions on androgen-responsive LNCaP cells
12. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): Regulation by cell surface follistatin
13. Signaling inputs converge on nuclear effectors in TGFbeta signaling
14. Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: Evidence for a secretion into cystic fluid
15. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: A potential role in autocrine growth regulation
16. Identification of an inhibin receptor in gonadal tumors from inhibin alpha-subunit knockout mice
17. Angiogenesis and endocrine tumours
18. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
19. The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4
20. Molecular cloning of the mouse activin beta E subunit gene
21. Prostate inhibin peptide (PIP) in prostate cancer: A comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP)
22. The role of stroma in prostate carcinogenesis
23. The mouse mahogany locus encodes a transmembrane form of human attractin
24. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
25. Studies in prostate cancer. I. The effects of castration, of estrogen and of androgen injection of serum phophatases in metastatic carcinoma of the prostate
26. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2
27. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
28. Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: Characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines
29. Molecular mechanisms of inactivation of TGFβ beta receptors during carcinogenesis
30. The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis
31. Inhibin in the male
32. Localization of inhibin and activin binding sites in the testis during development by in situ ligand binding
33. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways
34. Inhibin as a marker for granulosa-cell tumors
35. Structural analysis of the mouse activin beta C gene
36. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation
37. Transforming growth factor-beta in benign and malignant prostate
38. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling
39. Adenocarcinomas of various sites may exhibit immunoreactivity with anti-inhibin antibodies
40. Dual endocrine activity of the testis
41. Circulating immunoreactive inhibin levels during the normal human menstrual cycle
42. Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145
43. Expression of activin A and follistatin core proteins by human prostate tumor cell lines
44. Structure of two human ovarian inhibins
45. Activin receptors and cellular signaling by the receptor serine kinase family
46. Expression cloning of an activin receptor, a predicted transmembrane serine kinase
47. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice
48. Loss of the expression and localization of inhibin alpha-subunit in high grade prostate cancer
49. Co-localisation of activin betaC or betaA/betaB subunits in human prostate and evidence for formation of new activin betaC heterodimers
50. Novel cardiovascular actions of the activins
51. A novel role of activin in inflammation and repair
52. Comprehensive allelotyping of human hepatocellular carcinoma
53. The mahogany protein is a receptor involved in suppression of obesity
54. Molecular cloning and functional analysis of a new activin beta subunit: A dorsal mesoderm-inducing activity in Xenopus
55. Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family
56. Follistatin: A multifunctional regulatory protein
57. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding
58. Role of activins in the male reproductive tract
59. Isolation of inhibin from bovine follicular fluid
60. The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin
61. Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome
62. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues
63. Mouse models of prostate cancer
64. Crystal structure of a Smad MH1 domain bound to DNA: Insights on DNA binding in TGF-beta signaling
65. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: The role of activin as an autocrine growth factor
66. Follistatin binds to both activin and inhibin through the common subunit
67. Transforming growth factor-beta 1 overproduction in prostate cancer: Effects on growth in vivo and in vitro
68. A genome screen of multiplex sibships with prostate cancer
69. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell
70. Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate
71. Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer
72. Androgen-dependent gene expression of bone morphogenetic protein 7 in mouse prostate
73. Inhibins, activins, and follistatins: Expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia
74. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor
75. Alpha2-macroglobulin is a binding protein of inhibin and activin
76. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP
77. Identification of an activin-follistatin growth modulatory system in the human prostate: Secretion and biological activity in primary cultures of prostatic epithelial cells
78. Loss of heterozygosity at the alpha-inhibin locus on chromosome 2q is not a feature of human granulosa cell tumors
79. Regulation of cellular and system function by activin
80. Inhibin and activin locally regulate rat ovarian folliculogenesis
81. Recombinant human inhibin A and recombinant human activin A regulate pituitary and ovarian function in the adult female rat
82. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4
83. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism
84. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects
85. Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors
86. Inhibins, activins, and follistatins: Gonadal proteins modulating the secretion of follicle-stimulating hormone
87. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP
88. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer